Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · April 29, 2019

Palbociclib Plus Letrozole Improves Outcomes in HR+, HER2– Advanced Breast Cancer

Clinical Breast Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Breast Cancer
Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR+/HER2– Advanced Breast Cancer Enrolled in an Expanded Access Program
Clin. Breast Cancer 2019 Apr 18;[EPub Ahead of Print], A Brufsky, D Mitra, KL Davis, SP Nagar, L McRoy, MJ Cotter, V Stearns

Further Reading